Growing community of inventors

Combs la Ville, France

Patricia Vrignaud

Average Co-Inventor Count = 3.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 62

Patricia VrignaudMarie-Christine Bissery (3 patents)Patricia VrignaudMarielle Chiron-Blondel (2 patents)Patricia VrignaudPascale Lejeune (2 patents)Patricia VrignaudEric Steven Furfine (1 patent)Patricia VrignaudPatrick Mailliet (1 patent)Patricia VrignaudJesse M Cedarbaum (1 patent)Patricia VrignaudJocelyn Holash (1 patent)Patricia VrignaudClaudia Fromond (6 patents)Patricia VrignaudBrigitte Demers (1 patent)Patricia VrignaudJean-François Riou (1 patent)Patricia VrignaudJean-Francois Dedieu (1 patent)Patricia VrignaudClive Brealey (1 patent)Patricia VrignaudSimon Roberts (1 patent)Patricia VrignaudAkbar Khan (0 patent)Patricia VrignaudPatricia Vrignaud (6 patents)Marie-Christine BisseryMarie-Christine Bissery (22 patents)Marielle Chiron-BlondelMarielle Chiron-Blondel (4 patents)Pascale LejeunePascale Lejeune (3 patents)Eric Steven FurfineEric Steven Furfine (51 patents)Patrick MaillietPatrick Mailliet (23 patents)Jesse M CedarbaumJesse M Cedarbaum (14 patents)Jocelyn HolashJocelyn Holash (7 patents)Claudia FromondClaudia Fromond (6 patents)Brigitte DemersBrigitte Demers (3 patents)Jean-François RiouJean-François Riou (2 patents)Jean-Francois DedieuJean-Francois Dedieu (1 patent)Clive BrealeyClive Brealey (1 patent)Simon RobertsSimon Roberts (1 patent)Akbar KhanAkbar Khan (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Aventis Pharma S.a. (3 from 377 patents)

2. Sanofi (2 from 1,454 patents)

3. Regeneron Pharmaceuticals, Inc. (1 from 1,343 patents)

4. Aventis Pharma Rorer S.a. (1 from 1 patent)


6 patents:

1. 9259406 - Antitumor combinations containing antibodies recognizing specifically CD38 and melphalan

2. 8633301 - Antitumor combinations containing antibodies recognizing specifically CD38 and vincristine

3. 8388963 - Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof

4. 7851443 - Combination comprising combretastatin and anticancer agents

5. 6346543 - Use of a taxoid to treat abnormal cell proliferation in the brain

6. 6342487 - Compositions containing at least one farnesyl transferase inhibitor and at least one topoisomerase inhibitor and compositions containing at least one farnesyl transferase inhibitor and at least one taxoid

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/27/2025
Loading…